Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that Sean George, chief executive officer, will present at the Bank of America Merrill Lynch 2017 Health Care Conference on Thursday, May 18, 2017 at 10:40 a.m. Pacific in Las Vegas. Sean George will also participate in a panel discussion titled “Genetic Testing - Pricing, Payment and Policy in a Rapidly Growing Space” on Wednesday, May 17 at 4:20 p.m. Pacific.
The live webcast of the presentation may be accessed by visiting the Investors section of the company’s website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the company’s website.
Invitae Corporation's (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae’s goal is to aggregate most of the world’s genetic tests into a single service with higher quality, faster turnaround time, and lower price than many single-gene and panel tests today. The company currently provides a diagnostic service comprising hundreds of genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas. Additionally, the company has created a Genome Network to connect patients, clinicians, advocacy organizations, researchers, and therapeutic developers to accelerate the understanding, diagnosis, and treatment of hereditary disease. For more information, visit our website at invitae.com.